XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Balance Sheet Components    
Accrued commercial and research and development manufacturing $ 10,338 $ 21,774
Accrued co-development costs payable to Junshi Biosciences 4,559 8,356
Accrued royalties 13,189 5,015
Accrued other 9,282 10,634
Lease liabilities, current 4,446 4,318
Total Accrued and other current liabilities $ 41,814 $ 50,097